chr12-132606190-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001195520.2(LRCOL1):āc.62T>Cā(p.Met21Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000169 in 1,536,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001195520.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRCOL1 | NM_001195520.2 | c.62T>C | p.Met21Thr | missense_variant | 2/6 | ENST00000376608.9 | NP_001182449.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRCOL1 | ENST00000376608.9 | c.62T>C | p.Met21Thr | missense_variant | 2/6 | 1 | NM_001195520.2 | ENSP00000479730.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000148 AC: 2AN: 135366Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 73658
GnomAD4 exome AF: 0.0000181 AC: 25AN: 1384396Hom.: 0 Cov.: 30 AF XY: 0.0000117 AC XY: 8AN XY: 683152
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.62T>C (p.M21T) alteration is located in exon 2 (coding exon 1) of the LRCOL1 gene. This alteration results from a T to C substitution at nucleotide position 62, causing the methionine (M) at amino acid position 21 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at